As of 2024-12-14, the Fair Value of Genflow Biosciences PLC (GENF.L) is -2.19 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.60 GBP, the upside of Genflow Biosciences PLC is -236.85%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -0.99 | -1.34 | - | - | -1.16 | |
| YoY growth | -597.93% | -35.13% | - | - | -316.53% | |
| Market Cap (mil) | 5.60 |
| P/E | |
| Forward P/E |
| EPS | -0.44 |
| Avg earnings growth rate | -316.53% |
| TTM earnings | -1.53 |